Search
for
Sort by
Research 151–180 of 1000+
- Novel skin phenotypes revealed by a genome-wide mouse reverse genetic screen
- Epidermal abnormalities and increased malignancy of skin tumors in human epidermal keratin 8‐expressing transgenic mice
- The Role of Stem Cells in Cutaneous Wound Healing: What Do We Really Know?
- Evidence-based approach to cutaneous hyperandrogenism in women
- Cutaneous features of myotonic dystrophy types 1 and 2: Implication of premature aging and vitamin D homeostasis
- Perspectives in dermatopathology: telomeres and telomerase in ageing and cancer; with emphasis on cutaneous disease
- Combined therapy with adipose tissue-derived mesenchymal stromal cells and meglumine antimoniate controls lesion development and parasite load in murine cutaneous leishmaniasis caused by Leishmania amazonensis
- Epithelial–mesenchymal transition in cutaneous fibrosis disease: from mechanisms to therapy
- Cutaneous gain-of-function mutation of LRIG3 leads to alopecia by upregulation of ERBB, PI3K/AKT, NOTCH1 signaling pathways
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Identification and expression of the target gene SLC24A2 of oar-miR-377 and its novel SNPs effects on wool traits in sheep
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma
- Clinical manifestations of cutaneous lupus erythematosus
- Harnessing neuroendocrine controls of keratin expression: A new therapeutic strategy for skin diseases?
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- Epithelial‐to‐mesenchymal transition in cutaneous wound healing: Where we are and where we are heading
- Interferon in the treatment of cutaneous T-cell lymphoma
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Activin B Promotes BMSC-Mediated Cutaneous Wound Healing by Regulating Cell Migration via the JNK—ERK Signaling Pathway
- Cutaneous application of α-methylspermidine activates the growth of resting hair follicles in mice
- CUTANEOUS T-CELL LYMPHOMA
- Cutaneous manifestations of polycystic ovary syndrome
- Isolation and Characterization of Cutaneous Epithelial Stem Cells
- Innervated Biomaterials for Improved Cutaneous Wound Healing: A Review of Recent Advancements and Future Prospects
- Primary cutaneous follicle center lymphoma presenting as frontal fibrosing alopecia
- Nucleic acid-induced chemokine expression in keratinocytes: Implications for skin inflammation
- Severe cutaneous adverse reactions to drugs
- A Mouse Model for Conditional Expression of Activated β-Catenin in Epidermal Keratinocytes
- Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity
- Subacute cutaneous lupus erythematosus presenting as erythroderma